Photo taken from wemakescholars.com
Aug 7, 2024, 16:27
New e-learning on early relapsed/refractory myeloma by COR2ED
Lymphoma and Myeloma Connect shared on X:
“New e-learning on early relapsed/refractory myeloma! Learn to integrate the latest scientific insights into practice:
- Understand mode of action and efficacy of novel therapies.
- Best practices for treatment sequencing and combos.
- Manage side effects with knowledge of safety profiles.”
Additional information.
Source: Lymphoma and Myeloma Connect/X